As you can see, this stock has been maintaining a steady and consistent uptrend, showing strong price structure over time.
On the fundamental side, the story remains equally compelling, with a healthy upward revision to full-year guidance and notable confidence from major institutions that have been aggressively raising their price targets.
Management also increased full-year EPS guidance to a range of $7.50 to $7.74, up from the previous $7.02 to $7.36, which comes in comfortably above Wall Street’s pre-earnings consensus of around $7.31 to $7.32. Overall, both the technical trend and improving fundamentals appear aligned, supporting the ongoing bullish momentum.
On the fundamental side, the story remains equally compelling, with a healthy upward revision to full-year guidance and notable confidence from major institutions that have been aggressively raising their price targets.
Management also increased full-year EPS guidance to a range of $7.50 to $7.74, up from the previous $7.02 to $7.36, which comes in comfortably above Wall Street’s pre-earnings consensus of around $7.31 to $7.32. Overall, both the technical trend and improving fundamentals appear aligned, supporting the ongoing bullish momentum.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.